Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Biotechnology
... 8.5% over the analysis period 2024-2030. DNA Sequencing Market, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$33.5 Billion by the end of the analysis period. ... Read More
-
Bone Marrow Aspirate Concentrates
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Bone Marrow Aspirate Concentrates Systems, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$178.5 ... Read More
-
Chromatographic Silica Resins
... at a CAGR of 3.6% over the analysis period 2024-2030. Process Chromatography, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$63.8 Million by the end of ... Read More
-
Drug Discovery Technologies
... at a CAGR of 8.7% over the analysis period 2024-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$92.7 Billion by the end ... Read More
-
Marine Biotechnology
... CAGR of 8.4% over the analysis period 2024-2030. Biomaterials, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$6.5 Billion by the end of the analysis period. ... Read More
-
Arbovirus Testing
... CAGR of 5.9% over the analysis period 2024-2030. Public Health Laboratory, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$635.6 Million by the end of the ... Read More
-
Baking Enzymes
... CAGR of 5.0% over the analysis period 2024-2030. Carbohydrase, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$866.5 Million by the end of the analysis period. ... Read More
-
Cell Dissociation
... CAGR of 11.6% over the analysis period 2024-2030. Enzymatic Dissociation Products, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$506.9 Million by the end of the ... Read More
-
Electrochemical Instruments
... CAGR of 4.7% over the analysis period 2024-2030. Electrochemical Meters, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More
-
Gel Electrophoresis
... CAGR of 5.3% over the analysis period 2024-2030. Laboratory Research, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Genome Editing / Genome Engineering
... Billion by 2030, growing at a CAGR of 19.8% over the analysis period 2024-2030. CRISPR, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$18.7 Billion by ... Read More
-
Human Platelet Lysate
... at a CAGR of 3.7% over the analysis period 2024-2030. Clinical Use, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$77.7 Million by the end of ... Read More
-
Human Microbiome
... CAGR of 28.4% over the analysis period 2024-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Immunofluorescence Assays
... CAGR of 4.4% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.8 Billion by the end of the analysis period. ... Read More
-
Microbial Identification
... CAGR of 11.5% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$5.0 Billion by the end of the analysis period. ... Read More
-
Cloud-Based Drug Discovery Platforms
... 2030, growing at a CAGR of 14.3% over the analysis period 2024-2030. Pharmaceutical Vendors End-Use, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$3.0 Billion by ... Read More
-
Organs-on-Chips
... 35.3% over the analysis period 2024-2030. Liver, one of the segments analyzed in the report, is expected to record a 36.6% CAGR and reach US$206.0 Billion by the end of the analysis period. Growth in ... Read More
-
Diagnostic Specialty Enzymes
... at a CAGR of 6.2% over the analysis period 2024-2030. Polymerases & Nucleases, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$726.2 Million by the end ... Read More
-
Polymerase Chain Reaction
... at a CAGR of 5.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Primary Immunodeficiency Therapeutics
... at a CAGR of 6.4% over the analysis period 2024-2030. Antibody Deficiency, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$8.5 Billion by the end of ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Circular Dichroism Spectrometers
... at a CAGR of 4.8% over the analysis period 2024-2030. Linearly Polarized Light Sources, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$19.5 Million by the ... Read More
-
Cord Blood Banking Services
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Private, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$79.3 Billion by the end ... Read More
-
Automated Microscopy
... CAGR of 6.8% over the analysis period 2024-2030. Optical Microscopes, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$8.8 Billion by the end of the analysis ... Read More
-
Biochemical Reagents
... CAGR of 8.7% over the analysis period 2024-2030. PCR Reagent Kits, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$6.3 Billion by the end of the ... Read More
Research Assistance
